Gps Wealth Strategies Group, LLC Acurx Pharmaceuticals, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $818 Million
- Q2 2025
A detailed history of Gps Wealth Strategies Group, LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 23,500 shares of ACXP stock, worth $165,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,500
Previous 500
4600.0%
Holding current value
$165,205
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACXP
# of Institutions
36Shares Held
2.66MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$7.58 Million0.01% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$2.58 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$1.03 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$1.02 Million0.0% of portfolio
-
Morgan Stanley New York, NY106KShares$746,5930.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $81.2M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...